CBD Oils Disclaimer
Zilis products have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease or medical conditions. The information on the Zilis website, marketing materials, product labels or packaging is not intended as medical advice and should not substitute advice from a healthcare professional. Please consult with your physician or other healthcare provider if you have health-related questions before using any of our products or relying on any information you obtain from this website. You should discuss any medications or nutritional supplements you are using with a healthcare provider before using any new medications or supplements. Always review the labels, warnings, and directions included with your product before using or consuming the product and do not rely solely on the information shown on this website.
CLAIMS The US Food and Drug Administration (the “FDA”) and the Federal Trade Commission (the “FTC”) share responsibility in governing labeling ( FDA) and advertising (FTC) of dietary supplements to ensure that a company’s labeling and advertising claims are truthful, not misleading and substantiated. These agencies take an active role in their enforcement efforts in order to protect consumers and ensure that they are not mislead. Zilis products are not intended to diagnosis, treat or cure health problems, diseases or conditions. It is strictly prohibited to make any type of claim which expressly or implicitly implies that Zilis products have a positive effect on a disease. An example of an express claim would be: “Using CBD has been known to reduce Rheumatoid Arthritic inflammation.” Rheumatoid Arthritis is specific disease and linking the CBD oil to this disease is a disease claim. An example of an implicit claim would be: “The ingredients in Ultracell are the new ‘natural xeljanz’.” Since Xeljanz is associated with Rheumatoid Arthritis it would be characterized as a disease claim. Diseases encompass many different types of physical ailments including the common cold, addictions, and allergies. Zilis and its Ambassadors have a responsibility to provide truthful, non-misleading information to consumers about the benefits of our CBD Oil and supplement products when marketing the business. Ambassadors are strictly prohibited from making any claims about Zilis products on any social media platforms (private or public) or independent websites which expressly or implicitly imply that a product has a positive effect on a disease or, which is false, misleading, and unsubstantiated. This includes making statements such as: 100% legal in all 50 states, helps: reduce anxiety, joint pain, with movement disorders, seizures, and ADHD.